Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Aerosolizable Janus Protein Nanoparticles for Secondary and Tertiary Lung Cancer Chemoprevention.

Created on 17 Nov 2026

Authors

Albert Chang, Daren Wang, Fortune Shea, Aditya Kishan, Josh Flint, Susan R Mallery, Joerg Lahann

Published in

ACS applied bio materials. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Squamous cell carcinoma of the lung (LUSC) arises in the upper large airways of the lung. While this location appears to be readily accessible, barriers such as mucus, cilia, and resident phagocytes can limit the efficacy of inhaled chemopreventive agents. Adding to the challenges, aerosolization methods such as nebulization often induce mechanical and thermal stresses that can compromise the integrity of therapeutics and vehicles. Here, we report the aerosolization of anisotropic Janus protein nanoparticles (JNPs) prepared via electrohydrodynamic (EHD) co-jetting for co-delivery of the apolar molecule fenretinide (4HPR) and the monoclonal antibody tocilizumab (TCZ). Our findings show that JNPs experienced a marginal increase in diameter after aerosolization, from 391.3 ± 152.5 nm to 419.9 ± 168.4 nm. Scanning electron microscopy (SEM) and super-resolution confocal microscopy results confirmed minimal changes to particle morphology and preservation of the bicompartmental nature of JNPs. Furthermore, a dose-dependent study revealed that JNPs exhibit good stability in aerosols, which can be leveraged to adjust and maximize payload regardless of particle concentration. We further confirmed the retention of the therapeutics' bioactivity in vitro after aerosolization based on activation of caspase-3-mediated apoptosis and reduction of IL-6-induced STAT3-mediated signaling (via p-STAT3). Aerosolization of JNPs combines stability and preservation of biological function, and their bicompartmental design can be leveraged for further applications in co-delivery of synergistic drug combinations.

PMID:
43043289
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement